Virax Biolabs Group Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| XTX TOPCO LTD | 02/17/2026 | 21.44 K | $7.41 K | 100.00% | 0.45% |
| UBS GROUP AG | 01/29/2026 | 7.49 K | $2.59 K | 122.98% | 0.16% |
| NATIONAL BANK OF CANADA /FI/ | 02/17/2026 | 6.00 K | $2.07 K | -40.00% | 0.13% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 20 | $7 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 02/10/2026 | 10 | $3 | 100.00% | 0.00% |
| HRT FINANCIAL LP | 02/12/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 0 | $0 | -100.00% | 0.00% |
Virax Biolabs Group Ltd institutional Ownership - FAQ's
During the previous two years, 7 institutional investors and hedge funds held shares of Virax Biolabs Group Ltd. The most heavily invested institutionals were:
UBS Group AG: 0
XTX Topco Ltd: 21,437
NATIONAL BANK OF CANADA /FI/: 6,000
ADVISOR GROUP HOLDINGS, INC.: 20
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO: 10
Virtu Financial LLC: 0
0.73% of Virax Biolabs Group Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 27.47 K shares in the last 24 months. This purchase volume represents approximately $5.49 K in transactions.